Cheapest Wegovy HD Without Insurance in 2026: $249–$399 (9 Routes Priced)

By the WPG Editorial Team · Weight Loss Provider Guide
Last verified: August 24, 2026 · Next scheduled re-check: September 7, 2026

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. Some links on this page are affiliate links — if you click through and enroll, we may earn a commission at no extra cost to you. It does not change your price and it did not decide our conclusions. Several of the cheapest routes on this page pay us nothing, and we still put them first. Full disclosure.

The cheapest Wegovy HD without insurance is $249 per 28-day fill — but only if you buy 12 fills and put $2,988 down up front through a participating telehealth partner. Pay one fill at a time and the verified self-pay price is $399 at NovoCare Pharmacy, GoodRx, TrumpRx, Ro, WeightWatchers, and participating retail pharmacies. No current month-to-month route we verified undercuts it.

Here's the part that should annoy you: Novo Nordisk's March 31 press release still says the 7.2 mg dose will be added to the multi-month program “at a later date.” The live Ro and WeightWatchers pages now list it at $329, $299, and $249.

The dated announcement is stale. The live partner pages are current.

That gap is worth $1,800 over 12 fills — 336 days of medicine — and we'll show you exactly where to look.

Three things change your number:

• On Medicare Part D? Stop reading about cash prices. If you meet the exact Medicare GLP-1 Bridge rules, Wegovy HD is $50 per 28-day fill through December 31, 2027. Twelve fills cost $600, which is $4,188 less than twelve $399 cash fills. Jump there →
• Commercial insurance? Do not build your budget around $25. NovoCare's live checker currently says no insurance coverage is available for Wegovy 7.2 mg. If that changes and your plan covers HD, the manufacturer offer can reduce an eligible copay by up to $100, to as little as $25. See the current status →
• HSA or FSA card? NovoCare takes it at checkout. The sticker stays $399, but paying with eligible pre-tax funds can lower the tax-equivalent cost. Your real savings depend on your account and tax situation. See the math →

Not for you if: you're not an adult who has already tolerated Wegovy 2.4 mg for at least four weeks. The label reserves 7.2 mg for adults who meet that step and whose clinician says more weight reduction is indicated. No HD price on this page is available to you yet, and we'd rather say so now. Here's what to do instead →

Every way to pay for Wegovy HD, side by side

This is the table that puts every route on the same basis. Same columns, every route, one screen.

*Ro publishes the first $39 month and the next prepaid membership term separately. The charge stacks above add the displayed amounts, but the membership periods do not line up cleanly with 3, 6, or 12 medication fills. Your checkout screen controls. We will not turn that timing mismatch into a fake per-month comparison.

The number that should stop you: the medicine alone costs $2,988 for 12 prepaid fills or $4,788 one fill at a time. Same Wegovy HD. Same 336 days of labeled supply. A $1,800 spread. Add month-to-month Ro care and the 12-fill outlay reaches $6,466. Qualify for the Medicare Bridge and it falls to $600.

Those are different payer situations, so do not compare the endpoints as if they were the same offer. But do compare the route before you hand over a card.

Most people never learn there were nine doors.

The 30-second route picker

• Medicare Part D and possibly eligible: start with the Bridge, not cash.
• Prescription already in hand: NovoCare at $399, no membership.
• Need a prescriber and can prepay: compare WeightWatchers' documented $3,827 total with Ro's live checkout.
• Need a prescriber but cannot prepay: Ro month to month is the cleanest published no-lock-in route, but it is expensive.
• Commercial insurance: check the exact 7.2 mg dose, but do not assume your existing 2.4 mg approval carries over. NovoCare currently reports no HD coverage.

What we actually verified — August 24, 2026

We opened every first-party page ourselves today. No repeating another comparison article.

✅ $399 / $798 / $1,197 for one, two, and three fills — GoodRx's April 15, 2026 release.
✅ The $199 intro offer excludes HD — Novo's own footnote limits it to 0.25 mg and 0.5 mg starter pens.
✅ Published list price is $1,349.02 for the standard pen, HD pen, and Wegovy pill — Novo pricing materials.
✅ NovoCare's NPI, NCPDP, HSA/FSA policy, free shipping, 90-day option, and pharmacist claim codes — NovoCare's pharmacy pages.

⚠️ What we could not confirm and will not guess: whether Costco Pharmacy's Sesame price extends to the 7.2 mg dose; whether Hims & Hers is filling HD today; what the 13th fill costs after a 12-fill commitment; and Ro's exact medication-refund calculation after dispensing begins.

First, one free step. NovoCare's live checker currently says no commercial insurance coverage is available for the 7.2 mg injection. Run the official check before paying anyway, because that status can change. If it still says no, you have your answer and can stop waiting on a $25 outcome that is not presently there.

Check current Wegovy coverage on NovoCare →

What is the cheapest Wegovy HD without insurance in 2026?

Answer: Wegovy HD (semaglutide 7.2 mg) costs $399 per 28-day fill at the standard self-pay price, which covers one box of four weekly pens. Prepaying through a participating telehealth partner lowers the medicine to $329 per fill for three fills, $299 for six, or $249 for 12. The published list price without a self-pay program is $1,349.02.

Let's clear up the thing that confuses everyone first.

"One month" does not mean a calendar month. Novo defines one month as one box of four pens. You inject once a week. So one priced "month" is 28 days.

That matters more than it sounds like it does, and we'll come back to it in a minute with a number that surprised us.

What you actually get for $399

• One box
• Four single-dose prefilled pens
• 7.2 mg of semaglutide in 0.75 mL per pen
• One injection per week, any day, any time, with or without food
• Abdomen, thigh, or upper arm — rotate the spot each week

Buying in bulk doesn't help. We checked.

GoodRx publishes its Wegovy HD supply pricing openly:

Zero bulk discount. Not a dollar. On this route, a two- or three-fill order does not lower the per-fill price. NovoCare can fill a 90-day prescription if your prescriber writes one, but the larger shipment does not create a published price break.

So if someone tells you to "buy three months to save money," they have mixed up a larger pharmacy fill with a telehealth prepay commitment. They are not the same thing.

Which brings us to the $249.

Is the $249 Wegovy HD price real?

Answer: Yes. Ro and WeightWatchers list Wegovy HD at $249 per fill on a 12-fill commitment, $299 on six fills, and $329 on three fills, alongside the $399 one-fill-at-a-time price. The catch is that the discount is a commitment, not a coupon — 12 fills means $2,988 for medicine due up front.

This is the single most valuable thing on this page, so let's slow down.

The contradiction, in three official sources

The dated announcement still carries the old footnote. The live partner pages now include HD.

That's why some pages still tell you the cheap price isn't for you.

What the discount is worth

$150 per fill. 37.6% off. That is the whole economic case for prepaying.

Say this exact sentence

Ask for the dose, not just the brand:

"What's your prepay price on the 7.2 mg dose — the Wegovy HD?"

Say 7.2 mg or Wegovy HD, not just "Wegovy." That forces the person or checkout flow to show the HD terms rather than the standard-dose offer.

The honest catch — read this before you prepay

Here's the part we'd want told to us.

The $249 is not a $249 monthly bill. It's a prepayment. A 12-fill commitment means putting $2,988 for medication on your card up front, plus the required care membership. That's real money leaving your account in one motion.

And if you stop early, you do not automatically get every unshipped fill back at $249. WeightWatchers' published terms recalculate an eligible refund using the standard $399 HD price for the fills already shipped. That means part of the discount you already used comes out of the refund.

Ro is different: its public refund page says shipped prescriptions are final, but it does not publish one simple HD example showing how an unshipped annual medication commitment is recalculated. Do not assume WeightWatchers' formula applies to Ro. Save the exact terms shown at Ro checkout before you pay.

Ro does not let you pay $249 one fill at a time. If flexibility is what you need most — because you're not sure you'll tolerate the higher dose, because your job situation is shaky, or because $2,988 in one hit is not something you can do — then NovoCare Pharmacy at $399 a fill, no commitment, no membership, is the better answer for you, and we'd rather you took it.

But look at why the trade exists. Someone eligible for Wegovy HD has already moved through the standard titration and tolerated 2.4 mg for at least four weeks. If you and your clinician already expect treatment to continue, the commitment may be less of a gamble than it would be for a new starter.

There's no version of this where you get $249 and keep total flexibility. You pick one.

If you know you're staying on treatment, compare the live 12-fill terms before you move $2,988. Ro and WeightWatchers publish the same HD medicine price, but the care fees and refund language are not the same.

See Ro's Wegovy HD prices and prepay options →

Read WeightWatchers' 7.2 mg commitment terms →

Not sure yet? Skip the commitment. NovoCare Pharmacy is $399 a fill with no plan attached.

Wait — 12 fills isn't a year

Answer: A 12-fill injectable plan represents 336 days of labeled supply, not 365. One fill is one box of four weekly pens, or 28 days. Twelve boxes contain 48 pens. A yearly budget normally needs a 13th fill.

We almost missed this. Then we did the arithmetic.

• 1 box = 4 pens = 4 weeks = 28 days
• 12 boxes = 48 pens = 336 days
• 13 boxes = 52 pens = 364 days of listed supply

So the 12-fill commitment is 29 days short of a 365-day budget.

That's not a hidden dose. It is what happens when a product is priced in 28-day fills instead of calendar months. But it does mean two things:

1. Don't budget $2,988 as a literal 365-day medicine cost. Plan on a 13th fill.
2. Ask what fill 13 costs. If it stays $249, the medicine total becomes $3,237. If it reverts to $399 after the commitment, the total becomes $3,387. We could not verify how each provider handles that next fill, so ask before you sign.

That 336-day math is easy to miss. Now you have it.

Why don't the $149, $199, and $349 prices apply to me?

Answer: Because they belong to other doses or another product. The $199 introductory pen price is limited to 0.25 mg and 0.5 mg starter doses for the first two fills. The $149 and $299 prices are for the Wegovy pill. The $349 price is for the standard 0.25–2.4 mg pen. None of those standard offers can be applied to Wegovy HD.

You've seen a pile of numbers. Here's every current one, sorted, with a straight answer:

The thing hiding in plain sight

Wegovy HD's published list price is $1,349.02. The standard pen's published list price is $1,349.02. The Wegovy pill's published list price is $1,349.02.

All three are identical.

The public list-price data does not prove what any version costs to manufacture. It also does not reveal confidential rebates or what an insurer ultimately pays. What it proves is narrower and still useful: the published list price is not higher for HD. The $50 difference appears in the current self-pay program prices.

And the same list price does not guarantee the same coverage. The 7.2 mg pen has its own NDC and coverage rules. NovoCare's live checker currently says no commercial insurance coverage is available for it.

Can commercial insurance lower Wegovy HD to $25?

Answer: Not as a current, dependable route. Novo Nordisk's savings offer can lower an eligible covered commercial-insurance copay by up to $100, to as little as $25. But NovoCare's official checker currently says no insurance coverage is available for Wegovy injection 7.2 mg. Do not budget $25 until your plan confirms the exact HD product.

The words “as little as” matter. The offer does not erase any copay above $125. If your covered copay were $250, the $100 maximum saving would leave $150, not $25.

When you call your plan, ask about the exact product:

Wegovy injection 7.2 mg/0.75 mL — NDC 0169-4572-14

Ask three questions:

1. Is that NDC on the formulary today?
2. Does it require a new prior authorization even if 2.4 mg was approved?
3. What is the expected patient cost after the claim, before any manufacturer offer?

A general “Wegovy is covered” answer is not enough. Get the answer for 7.2 mg.

Check the current official status before you pay cash. The live NovoCare result is a better starting point than an article written from standard-dose coverage rules.

Check current Wegovy coverage →

On Medicare? You're looking at the wrong number entirely

Answer: Eligible Medicare Part D beneficiaries can get Wegovy HD for $50 per 28-day fill through the Medicare GLP-1 Bridge, not $399. The Bridge covers Wegovy injection and tablets for weight management, runs from July 1, 2026 through December 31, 2027, and uses a central processor outside normal Part D plan coverage.

We're putting this before the provider recommendation section on purpose, because if this is you, cash shopping may be a waste of your evening.

Twelve $399 fills versus twelve $50 fills is a $4,188 difference.

What you need

You must be at least 18, have eligible Medicare Part D coverage, receive the drug only to reduce excess body weight or maintain weight reduction, continue structured nutrition and physical activity consistent with the FDA label, and meet one of these criteria at the time you started GLP-1 therapy:

The Bridge is only for a prescription written solely for weight management. A request belongs with the Part D plan instead when the drug is prescribed for a Part D-coverable indication, including type 2 diabetes, moderate-to-severe obstructive sleep apnea, noncirrhotic metabolic dysfunction-associated steatohepatitis with moderate-to-advanced liver scarring, or Wegovy's major-cardiovascular-event risk-reduction indication. A past heart attack, stroke, or symptomatic peripheral artery disease can still satisfy the BMI 27 Bridge criterion when the prescription is solely for weight management.

You are also ineligible if a GLP-1 was already paid for through your Part D plan in 2026. Some Medicare plan types are excluded unless you also have a standalone Part D plan.

The order matters

The order is easy to get backward. CMS says the process starts at the pharmacy:

1. Your prescriber sends the covered prescription to the pharmacy. CMS recommends adding an obesity diagnosis code and “SEND TO BRIDGE FOR WEIGHT MANAGEMENT,” but says that annotation is not required for the claim to process.
2. The pharmacy sends the claim to the Bridge.
3. If you appear eligible, the pharmacy sends the prior-authorization request to the prescriber, usually within 24–72 hours.
4. The prescriber completes it. CMS says the decision is communicated within 72 hours of submission.
5. After the first approval, later fills and dose changes do not need a new PA unless you switch to a different covered GLP-1 drug.

Only 28-day or 30-day fills are covered.

If the PA is denied: the Bridge has no separate appeal process. The prescriber can resubmit when information was wrong or when new information is available. That is separate from any appeal rights you may have for a request that belongs under your Part D plan.

Four things people get wrong

1. The $50 doesn't count toward your Part D deductible or yearly out-of-pocket total. The Bridge operates outside the standard Part D benefit.

2. Extra Help doesn't lower it. The low-income subsidy does not reduce the Bridge price below $50.

3. You cannot put the $50 into the Medicare Prescription Payment Plan. Medicare's beneficiary fact sheet says Bridge drugs are not eligible for that payment plan.

4. Your Part D plan does not set or process this price. CMS uses a central processor outside Part D coverage and payment.

The part almost every page gets wrong

You'll read that Medicare beneficiaries are excluded from Novo's programs. That's only half the story.

Government beneficiaries are excluded from the $25 commercial copay offer. But Novo's savings materials say government-insured patients may use the self-pay program if the purchase is processed outside their insurance. Novo also tells pharmacies that a Medicare self-pay purchase must not count toward True Out-of-Pocket costs.

So a Medicare beneficiary who does not qualify for the Bridge is not locked out of the $399 route. They just cannot stack it with Part D.

We're not putting a provider button here. If you're on Medicare, the right first move is the Bridge process, and that pays us nothing. Go do that.

📄 Read CMS's current Medicare GLP-1 Bridge rules →

Which Wegovy HD route is cheapest for your situation?

Answer: It depends on three things — whether you already have a prescriber, how much you can pay at once, and whether you need ongoing clinical care. Someone with a prescription in hand pays $399 a fill at NovoCare with no fee. WeightWatchers publishes a clean $3,827 total for 12 HD fills plus 12 months of Med+ care. Ro lists the same $249 medicine price, but its first-month and annual membership periods do not produce a clean public apples-to-apples total. Someone using Ro month to month pays $438 for the first fill and $548 for each later fill.

There isn't one cheapest. There are three honest meanings of “cheapest,” and picking the wrong one is how people end up overpaying.

1. Lowest medicine price per fill — you can prepay
2. Lowest cash due today — you cannot
3. Lowest total that includes a prescriber — you do not already have one

Find yourself

→ You already have a prescriber who'll write 7.2 mg
Go straight to NovoCare Pharmacy. $399 a fill. No membership, no plan, no commitment.
Do not pay a telehealth fee to get access to something your own clinician can already prescribe. Details below →

→ You need a prescriber and you can prepay 12 fills
WeightWatchers publishes the cleanest all-in number: $3,827 for the 12-fill medicine commitment plus 12 months of Med+ care. Ro lists the same $2,988 medicine charge, but its membership starts at $39 and then moves to an $888 annual prepaid term after the first month. Compare the actual checkout timing before choosing.

→ You need a prescriber and you cannot prepay
Ro month to month is $438 for the first fill and $548 after that. Expensive, but clear — and you keep the ability to stop future renewals. The 3-fill medicine plan is a middle path only if you can put $987 for medicine down up front, plus the care charges.

→ Insurance is your real problem
Check the exact 7.2 mg NDC first. NovoCare currently reports no coverage. An insurance concierge can help with paperwork if a plan later creates a covered path, but no provider should sell you a $25 expectation today.

→ You're not on 2.4 mg yet
Don't sign up for anything built around HD. Read this instead →

The $14 comparison did not survive the source check

We originally did this math and got a tidy answer: WeightWatchers at $3,827, Ro at $3,841, a $14 difference.

It was too tidy.

*The Ro stack is not a clean 12-month comparison. Ro says the $888 annual membership is charged after the first $39 month, so the service period extends beyond the first month. Checkout controls the timing.

The earlier $3,841 number assumed the $39 first month replaced one of the $74 months. Ro's page does not say that. We removed the fake $14 tie instead of forcing the checkout to fit our conclusion.

That leaves a more useful decision:

Where Ro genuinely wins: a dedicated public Wegovy HD page, every medication tier visible, a broad GLP-1 care program, and an insurance concierge if coverage becomes available.

Where WeightWatchers genuinely wins: a fully published 12-fill total and a coaching-first program. If structured food support is part of how you keep weight off, that is a real reason to pick it, and we earn nothing by saying so.

If you need a prescriber for the 7.2 mg step-up, compare the live checkout pages after your clinician says the dose makes sense. Do not make a $3,000 decision from a blended “per month” number.

See Ro's live Wegovy HD options →

See WeightWatchers' 7.2 mg pricing and terms →

Do you even need a telehealth membership?

Answer: No — if you already have a clinician willing to prescribe the 7.2 mg dose. NovoCare Pharmacy is Novo Nordisk's direct-to-patient pharmacy. It fills an existing prescription at $399 per 28-day fill with no membership fee, ships free, accepts HSA and FSA payments, and can fill a 90-day prescription. It does not include a doctor.

This is the honest cheapest no-commitment answer for a lot of you, and it pays us nothing.

If your endocrinologist, PCP, or current telehealth provider already agrees you're ready for HD, you do not need to buy a second membership to get the medicine. Paying $74–$149 a month for access you already have is just money.

Give your prescriber this card

One thing that can go wrong: the prescriber's software cannot find “NovoCare.” Here's what they need.

NovoCare Pharmacy
2400 Sand Lake Rd, Ste. 200B
Orlando, FL 32809
Phone: 1-833-949-5527
Fax: 1-833-947-0246
NPI: 1710671854
NCPDP: 5758074
Wegovy HD NDC: 0169-4572-14

If it still will not come up, the prescriber can add the pharmacy manually with that information.

Already have your prescription at another pharmacy? Ask the current pharmacy to transfer it to NovoCare. If the prescription status or state rule prevents a transfer, ask your prescriber to send a new electronic prescription.

Who actually ships it: NovoCare Pharmacy is CoAssist Pharmacy doing business as NovoCare Pharmacy, with CenterWell Pharmacy as another dispensing partner and AssistRx handling intake and support. That's why the text messages may come from names you do not recognize. It's not a scam — it's the published fulfillment chain.

One limit worth knowing: NovoCare Pharmacy does not accept a copay card. You do not need one for its published self-pay price. The pharmacist billing steps below are for a participating local pharmacy using the savings offer.

The pharmacy counter fix most consumer pages miss

If you're picking up locally with the savings offer and it rejects, the billing setup can be one cause. Novo publishes the exact processing paths for pharmacists.

Show your pharmacist this:

Pharmacist help line: 1-844-373-0987.

Print that. Take it with you. It can turn a failed savings-offer claim into a properly processed one.

Have a prescription already? Skip the membership entirely.

Send your prescription to NovoCare Pharmacy — $399, no membership →

This is not an affiliate link. It is the cleanest no-membership route we verified.

Can you use an HSA or FSA for Wegovy HD?

Answer: Yes. NovoCare Pharmacy accepts HSA and FSA payments directly, and prescription medicine is generally a qualified medical expense. The $399 sticker does not change. The benefit comes from using eligible pre-tax dollars, so the tax-equivalent cost depends on how your account was funded, your marginal tax rates, your state's rules, and the amount available in the account.

This is real money many people leave on the table.

Illustrative math only: if the total tax saved on the dollars going into your account is 30%, then $399 paid with those dollars is equivalent to about $279 of after-tax income.

At a 30% illustrative rate, the difference is roughly $1,436 across 12 fills. Remember: 12 injectable fills represent 336 days, not a literal calendar year.

This is not a manufacturer discount, and it is not guaranteed tax savings. Contributions made outside payroll may be treated differently from payroll deductions, state rules vary, and an FSA or HSA administrator can deny a charge that does not meet the plan's rules.

Who takes the card, and who makes you file paperwork

That Ro limitation is real and worth knowing before checkout. It does not automatically erase eligibility for reimbursement. It costs you convenience, and it makes recordkeeping your job.

Medication and membership fees are not always treated the same way. A prescription can qualify while a broad coaching or membership charge does not. Check with your plan administrator and keep the receipt. We're a comparison resource, not tax advisers.

Can you just use three 2.4 mg pens instead?

Answer: No — not as an FDA-labeled substitute, and not on your own. Wegovy HD is a separate single-dose pen containing 7.2 mg in 0.75 mL. Three 2.4 mg injections would be an off-label dosing approach that adds injection and dosing-error risk. It also costs more: three standard boxes at $349 each total $1,047, which is $648 more than one HD box.

We're answering this because people genuinely ask it, and the math is worth seeing.

On the label: the HD pen delivers 7.2 mg in one weekly injection. The standard maintenance pen delivers 2.4 mg in one weekly injection. Dose changes go through the prescriber.

On money:

The “hack” costs $648 more per 28-day fill cycle. Across 12 cycles, that is $7,776 more.

It is not the labeled route, it creates more room for error, and it costs more. That settles the question.

Is Wegovy HD cheaper than Zepbound at the top dose?

Answer: Yes per eligible discounted fill. Wegovy HD is $399 per 28-day fill. The current Zepbound KwikPen offer is $449 for the 15 mg dose when the offer rules are met, a $50 difference per fill. Do not turn that into a guaranteed $600 yearly saving: Lilly limits the KwikPen savings card to up to 11 fills per calendar year, requires refill purchase within 45 days for the Journey price, and lists a $699 regular price for 15 mg when the timing rule is missed.

Everyone compares starter prices. Almost nobody compares the current conditions at the ceiling — which is exactly where you're standing.

Wegovy HD undercuts the current top-dose Zepbound offer by $50 per eligible fill. Across 11 discounted Zepbound fills, the difference is $550. A 12th fill cannot be assumed at the same offer price.

The caveat we won't bury: those percentages come from separate trials with different designs and different participants. We found no published head-to-head trial of Wegovy HD against Zepbound as of August 24, 2026. Anyone telling you one definitively beats the other at these doses is going past the evidence.

What we can say cleanly: HD is cheaper per current discounted top-dose fill. The clinical choice is not a price table, and switching medicines can change titration, coverage, and side effects. That decision belongs with your clinician.

Is the higher dose worth $50 more per fill?

Answer: In FDA's treatment-policy analysis of STEP UP, Wegovy 7.2 mg produced 18.8% average body-weight reduction over 72 weeks, compared with 15.5% at 2.4 mg and 3.9% on placebo. About one in three participants on 7.2 mg lost at least 25% in the trial's on-treatment reporting. The self-pay difference between 2.4 mg and 7.2 mg is $50 per 28-day fill. Side effects were more common at the higher dose.

Straight numbers, so you can have the right conversation instead of guessing.

What the trial found

STEP UP enrolled 1,407 adults with obesity and no diabetes and ran for 72 weeks.

Sources: FDA-approved Wegovy prescribing information and Wharton S, et al., “Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP),” Lancet Diabetes & Endocrinology, 2025.

A note on the numbers you'll see elsewhere: 18.7%, 18.8%, and 20.7% can all be accurate because they come from different estimands or analysis populations. The FDA label's treatment-policy figure is 18.8%. The published paper reports 18.7% in its stated primary analysis. The 20.7% headline came from an on-treatment estimate. They should be labeled, not mixed together.

The cost per extra pound

Rough, but useful. The FDA treatment-policy difference between 7.2 mg and 2.4 mg is 3.3 percentage points. For someone starting at 250 pounds, that equals about 8 additional pounds on average over 72 weeks.

Seventy-two weeks contains 18 four-week fill cycles. At $50 more per fill, the extra medicine cost is about $900 over that trial-length window.

That is not a promise that any one person will lose eight more pounds, and it is not a reason by itself to move up. It is simply a concrete way to see the trade: about $900 more over 72 weeks for the trial's average 3.3-point difference, with more side effects.

The side effects get worse. Here's exactly how much.

Straight from the FDA prescribing information:

Most of it shifts a few points. Two things stand out: vomiting rises from 16% to 22%, and hair loss rises from 3% to 6%.

And one side effect that stands out at this dose

Dysesthesia is the medical word for odd skin sensations such as burning, tingling, numbness, itching, or unusual sensitivity without an obvious cause.

• 22% on 7.2 mg
• 6% on 2.4 mg
• Under 1% on placebo

Most cases were mild. The FDA label also reports more dose reductions and treatment stops for these sensations at 7.2 mg than at 2.4 mg. The label does not give a simple 6–12 week rule for when the sensations will ease.

That's more than one in five. It is not a reason to panic or a promise that it will happen to you. It is a reason to know the word before it happens, so you contact your clinician instead of changing the dose on your own.

The dose is not a one-way door. A clinician can reduce or stop it when the risk-benefit trade changes. Do not change it without them.

If you're plateaued on 2.4 mg and the numbers above look like a trade worth discussing, that is the point of the 7.2 mg option — a clinician-guided next step, not an automatic upgrade.

Compare the care routes only after the dose conversation →

The case for staying right where you are

Answer: Wegovy HD is not automatically the better choice just because it is a higher dose. If you are still losing weight steadily on 2.4 mg and tolerating it, the standard dose is producing the result you're paying for. Staying at 2.4 mg costs $50 less per 28-day fill and had lower side-effect rates in STEP UP.

We'd rather you skipped this dose than regretted it.

Do not rush the step-up if:

• You're still losing steadily on 2.4 mg. It is working. Let it work while you and your clinician decide whether more dose adds enough value.
• You have not done four full weeks at 2.4 mg. You are not eligible under the label yet.
• $399 would mean skipping food, housing, another prescription, or something else that protects your health. A weight-loss medication should not create a different kind of health problem.
• The dysesthesia or vomiting numbers bother you more than the plateau does. That's a valid read.

Cheaper options that are still FDA-approved brand-name medication:

• Stay on Wegovy 2.4 mg — $349 per 28-day fill, or lower on a qualifying multi-fill commitment
• Wegovy pill at 25 mg — $299 per 30-day fill, no injections, and roughly 14% average weight reduction in its own trial. Cheaper, oral, and a different product with different evidence. Not the same thing, and we will not pretend it is.

See the current price decoder on this page →

What if you're not on Wegovy 2.4 mg yet?

Answer: Wegovy HD is not available to you yet, and no price changes that. The FDA-approved label directs that the 7.2 mg dose be used only after an adult has tolerated Wegovy 2.4 mg for at least four weeks and additional weight reduction is clinically indicated. Reaching 2.4 mg from the normal starting dose takes about 16 weeks, so the minimum labeled path to the HD conversation is roughly five months.

Here's the ladder:

The three-part readiness check:

1. Are you an adult taking Wegovy 2.4 mg right now?
2. Have you tolerated it for at least four weeks without needing to drop back?
3. Has your clinician said more weight reduction is medically worth pursuing?

Three yeses means you are a candidate for a conversation — not that you automatically qualify. That's your clinician's call.

Any nos? Don't pay for a program built around a dose you cannot get yet. That's the most common expensive mistake on this topic.

If you used compounded semaglutide before: talk to your clinician about how to start authentic Wegovy. A compounded product is not dosed under the Wegovy label, and the prior dose does not automatically translate to a Wegovy starting or maintenance dose. Do not make that conversion yourself.

Not there yet? Find the right starting point instead of the wrong finish line.

Take the free 60-second GLP-1 matching quiz →

How to spot a fake Wegovy HD offer

Answer: Authentic Wegovy HD is the FDA-approved 7.2 mg semaglutide injection made by Novo Nordisk and requires a prescription. A compounded semaglutide product is not Wegovy HD, even if it is offered at a 7.2 mg amount or described with similar language. FDA says compounded drugs are not FDA-approved generics and marketers may not claim they are the same as, generic versions of, or clinically proven like an FDA-approved drug.

You've been on this medication for months. You'd probably spot most of it. But this dose is new enough that the marketing has not settled.

What a trustworthy offer should show before you pay:

• A prescription is required, full stop
• A licensed clinician evaluates you
• The words “Wegovy HD” or “7.2 mg” appear on the actual brand-product page
• The dispensing pharmacy or pharmacy network is identified before payment
• Medication price and program fee are listed separately

Treat these as warning signs:

• “Wegovy HD” without a prescription
• A price dramatically below $249 with no clear commitment, manufacturer offer, or payer explanation
• No pharmacy or pharmacy network named before payment
• Anything blurring compounded semaglutide with Wegovy HD
• Language calling a compounded product “generic Wegovy”

Is there a generic Wegovy HD? No FDA-approved generic version of Wegovy exists as of August 24, 2026.

Compounding can occur only under specific federal and state conditions. That does not make a compounded product Wegovy, a generic Wegovy, therapeutically equivalent to Wegovy, or FDA-approved. It belongs in a different decision, not beside a brand-name HD price as if the products were interchangeable.

What we deliberately left off this page

Three quick things, because what a comparison page omits tells you as much as what it includes.

No compounded providers. There is no FDA-approved compounded equivalent or generic version of Wegovy HD. Federal law can permit patient-specific compounding in limited circumstances, but that is a different product category with different oversight. We will not present it as a cheaper box of the FDA-approved brand.

No discount-card quote above the manufacturer price. Third-party card pages can show cash figures well above $399. Listing a higher number as a “savings option” would be misleading when verified manufacturer-linked routes sell the dose for $399. If a card beats $399 for the 7.2 mg dose specifically, we will add the exact pharmacy, date, and terms.

No star rating. We have not collected verified purchases for this dose, so we are not publishing a score or adding review markup to make one appear.

What real customers say about these services

Service experiences only. None of these comments are evidence about whether the medication works — that's what the trial data above is for.

“Ro was prompt with answers to my multiple questions.”
— Oregon customer, Trustpilot, August 16, 2026 (invited review, 4 stars)

“The entire process of requesting the medication ... was very easy.”
— Julie, Trustpilot, August 11, 2026 (invited review, 4 stars)

How to read these: individual comments are anecdotal and may not reflect a typical experience. They describe service, not medical results. Trustpilot labels both as invited reviews.

And the honest other side. Public reviews also include complaints about unclear pricing, unexpected charges, and trouble reaching support. Those are customer allegations, not proven findings. The official terms do confirm the structure underneath them: Ro bills medicine separately from membership, longer plans require prepayment, and shipped prescription products are final. WeightWatchers also separates the Med+ fee from the medicine commitment and recalculates eligible HD refunds using the $399 standard price.

Which is exactly why we built the table with separate medicine and care columns instead of one blended number.

Your step-by-step, from here

Answer: Confirm the 7.2 mg dose is clinically appropriate, decide whether you need a new prescriber, check the exact insurance status before committing to cash, set an upfront limit you can live with, read the refund terms, and save the offer before you pay.

1. Confirm you're eligible. Adult, on 2.4 mg, at least four weeks tolerated, clinician agrees more weight reduction is indicated.

2. Check the exact insurance status. NovoCare currently says no commercial coverage is available for 7.2 mg. Run the current check anyway. Do not confuse a standard-dose approval with an HD approval.

3. Decide if you need a prescriber.

• Yes → compare Ro and WeightWatchers
• No → NovoCare direct at $399

4. Pick your commitment level. How much can you comfortably put down today? $2,988 is not a small number. If it is a stretch, do not let a lower per-fill price talk you into a bad cash decision.

5. Read the refund terms before you enter a card. Specifically: what happens to unshipped fills, what price is used to recalculate them, whether shipped medicine is final, and when the care plan renews.

6. Confirm your state. National marketing does not mean every clinician or service is available in every state. Check service eligibility before you pay.

7. Screenshot everything. Medicine price, care fee, amount due today, plan length, renewal date, refund terms, provider name, and pharmacy name. Save it. Terms change, and a dated screenshot is worth more than a memory.

How we built this page

Who: the WPG Editorial Team at Weight Loss Provider Guide, an independent comparison resource for GLP-1 telehealth providers. We do not own or operate a telehealth platform.

How: We used FDA materials and the current prescribing information for medical and regulatory claims. For prices and policies, we opened each provider's first-party page on August 24, 2026 and read the footnotes. We kept medicine and care fees separate, did the arithmetic ourselves, and marked what we could not confirm.

Why this page exists: because most Wegovy cost pages treat the 7.2 mg dose as one line in a general table, while the largest current discount is hidden inside multi-fill terms and the current commercial-coverage status changes the answer above the fold.

Our conflicts: we earn commissions from some providers named here and none from others. NovoCare, WeightWatchers, GoodRx, CMS, and retail pharmacies do not pay us for the order or conclusions on this page.

Provider-stated versus checked

“Verified” here means the statement matched a first-party page, federal document, FDA label, or published trial on the verification date. It does not mean we completed a secret-shopper purchase.

Sources

• NovoCare Wegovy coverage checker
• NovoCare Wegovy savings offer and current cash prices
• NovoCare Pharmacy patient page
• NovoCare Pharmacy prescriber information
• Ro Wegovy HD 7.2 mg page
• Ro weight-loss pricing and membership terms
• Ro payment-method and refund FAQ
• WeightWatchers Wegovy and Med+ pricing
• GoodRx April 15, 2026 Wegovy HD pricing release
• Novo Nordisk March 31, 2026 multi-month announcement
• CMS Medicare GLP-1 Bridge
• CMS Bridge information for prescribers
• Medicare beneficiary Bridge fact sheet
• Current Wegovy prescribing information, revised June 2026
• Wharton S, et al., STEP UP trial
• FDA statement on non-FDA-approved GLP-1 marketing
• FDA compounding questions and answers
• IRS Publication 969
• Zepbound savings terms
• LillyDirect Zepbound pricing
• Foundayo savings terms
• Current Ro customer reviews on Trustpilot

Still unverified: whether Costco Pharmacy's Sesame price extends to the 7.2 mg dose · whether Hims & Hers is filling HD prescriptions today · the price of the 13th fill after a 12-fill commitment · Ro's exact refund calculation for an unshipped HD medication commitment.

Frequently asked questions

How much does Wegovy HD cost without insurance?
$399 per 28-day fill at the standard self-pay price, covering one box of four weekly single-dose pens. Multi-fill commitments lower the medicine to $329 for three fills, $299 for six, or $249 for 12. Care fees are separate.

Is the $249 Wegovy HD price real?
Yes. Ro and WeightWatchers list it. The catch is that it is a 12-fill prepayment: $2,988 for medicine due up front, not a $249 monthly bill.

Why is Wegovy HD more expensive than regular Wegovy?
The published list price is the same — $1,349.02 for HD, the standard pen, and the pill. The $50 difference appears in the current self-pay program prices. That does not reveal manufacturing cost, insurer rebates, or a plan's net cost.

Can I use the $199 Wegovy offer on the 7.2 mg dose?
No. The $199 offer is limited to 0.25 mg and 0.5 mg starter pens for the first two eligible fills. HD is $399 one fill at a time.

Does the $25 savings offer work on Wegovy HD?
Only if commercial insurance actually covers the 7.2 mg product. The offer saves no more than $100 per fill and can lower an eligible copay to as little as $25. NovoCare's live checker currently says no insurance coverage is available for 7.2 mg, so this is not a dependable current route.

Is Wegovy HD covered by the Medicare GLP-1 Bridge?
Yes for eligible Medicare Part D beneficiaries using it solely for weight management, continuing structured nutrition and physical activity, and meeting the exact CMS criteria. The price is $50 per 28-day fill. The pharmacy starts the Bridge claim, then sends the PA request to the prescriber.

Does buying three fills of Wegovy HD at once save money through a pharmacy?
No. GoodRx lists $399 for one fill, $798 for two, and $1,197 for three. The per-fill price only drops when you enter a separate multi-fill commitment program.

Is a 12-fill Wegovy plan a full year?
No. One injectable fill is 28 days. Twelve fills represent 336 days. A 365-day budget normally needs a 13th fill.

Can I pay for Wegovy HD with an HSA or FSA?
NovoCare accepts HSA and FSA payments directly. Ro does not accept the cards at checkout but says it can provide a detailed receipt for reimbursement. Eligibility and tax treatment depend on your account and plan.

Do I need a telehealth membership to get Wegovy HD?
No. If a clinician already prescribes it, NovoCare Pharmacy can fill it for $399 with no membership and free shipping.

Can I start Wegovy at 7.2 mg?
No. The FDA label directs that adults use 7.2 mg only after tolerating 2.4 mg for at least four weeks and when a clinician says additional weight reduction is indicated.

Is Wegovy HD cheaper than Zepbound?
Per current eligible top-dose fill, yes: $399 versus $449. The difference is $50 per fill, not a guaranteed $600 per year, because the current Zepbound KwikPen offer has a 45-day refill rule and a maximum of 11 fills per calendar year.

Is compounded 7.2 mg semaglutide the same as Wegovy HD?
No. Wegovy HD is an FDA-approved Novo Nordisk product. Compounded semaglutide is not an FDA-approved generic or equivalent, even when a marketer uses a similar dose or brand-like wording.

What happens to my price if I go back down to 2.4 mg?
The current standard-pen self-pay price is $349 per 28-day fill, $50 less than HD. If you are in a commitment, ask how the provider handles a dose change before paying; the rule is not published the same way across every provider.

Still not sure which GLP-1 program is right for you?

Take our free 60-second matching quiz. Tell us your current dose, insurance, budget, whether you already have a prescriber, and how much you can prepay. We'll show you the route that fits and the exact next question to ask.

Get my personalized GLP-1 action plan →

Related guides

• Find your GLP-1 path in 60 seconds
• Wegovy prior authorization — criteria, forms, and what to do if denied
• GLP-1 providers that accept Medicare — including the $50 Bridge

Last verified: August 24, 2026. Program terms can change at any time at the manufacturer's or provider's discretion. Confirm current pricing on the official pages before you pay. Found something out of date? Email editorial@weightlossproviderguide.com — we correct fast and credit the reader.

Medical disclaimer: This article is for general information and is not medical advice. Wegovy is a prescription medication with serious warnings. Wegovy carries a boxed warning for thyroid C-cell tumors: thyroid C-cell tumors have been observed in rodents, and it is not known whether Wegovy causes thyroid C-cell tumors, including medullary thyroid carcinoma, in humans. Wegovy is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and in anyone who has had a serious allergic reaction to semaglutide or an ingredient in Wegovy. Other serious risks include pancreatitis, gallbladder problems, low blood sugar, dehydration that can lead to kidney problems, serious allergic reactions, changes in vision in people with type 2 diabetes, and increased heart rate. Talk to a licensed clinician before starting, stopping, or changing any GLP-1 medication. Read the current prescribing information.

About Weight Loss Provider Guide: We are an independent comparison resource for GLP-1 telehealth providers. We do not own or operate a telehealth platform. Our editorial priority is accuracy and reader fit; affiliate relationships do not determine the order or emphasis of our recommendations. Advertising disclosure · Editorial standards · Corrections